HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.

AuthorsXiaojing Cheng, Kelong Fan, Lin Wang, Xiangji Ying, Andrew J Sanders, Ting Guo, Xiaofang Xing, Meng Zhou, Hong Du, Ying Hu, Huirong Ding, Ziyu Li, Xianzi Wen, Wenguo Jiang, Xiyun Yan, Jiafu Ji
JournalCell death & disease (Cell Death Dis) Vol. 13 Issue 11 Pg. 998 (Nov 25 2022) ISSN: 2041-4889 [Electronic] England
PMID36433933 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: